Location History:
- Octeville sur Mer, FR (2011 - 2014)
- Gévezé, FR (2021 - 2024)
Company Filing History:
Years Active: 2011-2024
Title: The Innovative Contributions of David Perrin
Introduction
David Perrin is a notable inventor based in Octeville-sur-Mer, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel combinations of medications. With a total of seven patents to his name, Perrin's work focuses on enhancing therapeutic efficacy through innovative drug combinations.
Latest Patents
Among his latest patents are two significant inventions: "Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof." This invention discloses combinations of a H3 antagonist and an antidepressant, which exhibit a synergistic wake-promoting activity. The second patent, also titled "Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof," relates to similar combinations that enhance wakefulness and therapeutic outcomes.
Career Highlights
David Perrin has worked with prominent companies in the pharmaceutical industry, including Sidel Participations and Bioprojet. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medication and treatment options.
Collaborations
Throughout his career, Perrin has collaborated with esteemed colleagues such as Zmaj Petrovic and Xavier Ligneau. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.
Conclusion
David Perrin's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving therapeutic practices. His work continues to influence the industry and offers promising advancements in medication efficacy.